Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory blockade improves human pancreatic islet function and viability.

Zandong Yang1, Meng Chen, Justin D Ellett

  • 1Department of Internal Medicine, Division of Endocrinology, Metabolism, University of Virginia, Charlottesville, VA 22908, USA. zy4q@virginia.edu

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
|February 15, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

12-Lipoxygenase (12-LOX) plays a key role in the hyperinflammatory response caused by SARS-CoV-2.

mBio·2026
Same author

Multi-ancestry polygenic risk scores for the prediction of type 2 diabetes and complications in diverse ancestries.

medRxiv : the preprint server for health sciences·2025
Same author

Precision Medicine in Surgery: Immunomodulation and Cellular Regeneration Strategies for Immunologic and Surgical Diseases.

Annals of surgery·2025
Same author

Large-scale multi-omics analyses in Hispanic/Latino populations identify genes for cardiometabolic traits.

Nature communications·2025
Same author

12-Lipoxygenase Inhibition Improves Glycemia and Obesity-associated Inflammation in Male Human Gene Replacement Mice.

Endocrinology·2025
Same author

Joint analysis of the nPOD-Virus Group data: the association of enterovirus with type 1 diabetes is supported by multiple markers of infection in pancreas tissue.

Diabetologia·2025

Lisofylline (LSF) protects human pancreatic islets from inflammation and enhances insulin secretion. This anti-inflammatory compound reduces beta-cell death and improves islet transplantation outcomes in diabetic mice.

Area of Science:

  • Endocrinology
  • Immunology
  • Cell Biology

Background:

  • Pancreatic beta-cell death contributes to diabetes mellitus pathogenesis.
  • Inflammation is a key factor implicated in beta-cell loss during diabetes development.

Purpose of the Study:

  • To investigate the protective role of the novel anti-inflammatory compound Lisofylline (LSF) in human pancreatic islets.
  • To assess LSF's impact on beta-cell function and survival under inflammatory conditions.

Main Methods:

  • Treatment of human islets with Lisofylline (LSF) in the presence of proinflammatory cytokines.
  • Assessment of glucose responsiveness, insulin secretion, apoptosis, and cellular viability.
  • Evaluation of LSF-treated islets in a mouse islet transplantation model.

Related Experiment Videos

Main Results:

  • LSF retained glucose responsiveness and insulin secretion in human islets exposed to proinflammatory cytokines.
  • LSF enhanced basal insulin secretion and significantly reduced islet apoptosis and damage.
  • Islet transplantation in diabetic mice required 30% fewer LSF-cultured islets to achieve insulin independence.

Conclusions:

  • Lisofylline (LSF) significantly enhances human beta-cell function and viability by blocking inflammatory pathways.
  • LSF demonstrates potential as a therapeutic agent to improve beta-cell function for islet transplantation in diabetes treatment.